Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
NCT Number: NCT02425514
The purpose of this study is to evaluate the efficacy and safety of NovoMax™ in Anterior Cervical Interbody Fusion - Comparison of NovoMax™ versus ChronOs®.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ACDF surgery will be carried out with Cervios ChronOs after randomization procedure.
The ACDF surgery will be carried out with NovoMax™ after randomization procedure.
Time frame: at 6 months after surgery (ACDF)
Evaluation of bone fusion between bone substitutes and cervical vertebral endplates with 3-dimensional CT and X-ray at 6 months after operation (ACDF).
Time frame: at 6 months after surgery (ACDF)
Evaluation of neck pain using the visual analogue scale (VAS) at 6 months after operation (ACDF). Reported pain using VAS was recorded and evaluated. Patients were instructed to make a mark on a horizontally-oriented, 10-point VAS labeled "no pain (zero point)" at the far left and "greatest pain (ten point)" at the far right.
BioAlpha Inc.
Industry
Evaluation of Bone Union Following Anterior Cervical Fusion Using a Bioactive Glass-Ceramic Spacer (NovoMax™): Comparison With a PEEK Cage Filled With β-Tricalcium Phosphate (Cervios ChronOs™)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01615328
Bone Diseases, Hernia
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT00310440
Bone Diseases, Intervertebral Disc Degeneration
San Francisco, California, United States
View Trial DetailsNCT07670039
Bone Diseases, Facet Joint Arthritis
Moscow, Russia
View Trial DetailsNCT06989632
Bone Diseases, Hernia
Valencia, Spain
View Trial Details